Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer

doi:10.5306/wjco.v15.i5.635

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (464)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

297

Figures (1-2)

Tables (1-2)

Sum=394

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=57

May 24, 2024 (publication date) through Jun 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. May 24, 2024; 15(5): 635-643
Published online May 24, 2024. doi: 10.5306/wjco.v15.i5.635

Full Size Figure Download Figure

Figure 1 Progression-free survival of clinicopathological factors. A: The progression-free survival (PFS) of different combined positive scores of programmed cell death 1 ligand 1; B: PFS according to different human epidermal growth factor receptor 2 expression levels; C: PFS according to Epstein-Barr virus-encoded small RNA status; D: PFS according to patient gender; E: PFS according to different numbers of metastatic organs; F: PFS according to different performance status scores.

Citation: Ma XT, Ou K, Yang WW, Cao BY, Yang L. Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer. World J Clin Oncol 2024; 15(5): 635-643
URL: https://www.wjgnet.com/2218-4333/full/v15/i5/635.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i5.635